TCM
TBIO

TimesSquare Capital Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

TimesSquare Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,367
Closed -$3.13M – 209
2022
Q1 		$3.13M Sell
32,367
-1,244
-4% -$189K 0.04% 192
2021
Q4 		$6.53M Sell
33,611
-256
-0.8% -$39.8K 0.06% 192
2021
Q3 		$6.79M Sell
33,867
-2,061
-6% -$523K 0.06% 206
2021
Q2 		$14.2M Buy
+35,928
New +$12.7M 0.12% 190

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TimesSquare Capital Management's TBIO Position: Q2 2022 in Review

TimesSquare Capital Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2022, closing a stake of 32,367 shares — an estimated $3.13M sold.

TimesSquare Capital Management first reported a position in TBIO in Q2 2021 and held it in 4 quarters. The position peaked at $14.2M in Q2 2021. 37 funds tracked by Wall St. Rank hold TBIO as of Q2 2022.

  • TimesSquare Capital Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • TimesSquare Capital Management sold 32,367 Telesis Bio, Inc. Common Stock shares in Q2 2022, an estimated $3.13M.
  • TimesSquare Capital Management first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • TimesSquare Capital Management's Telesis Bio, Inc. Common Stock position peaked at $14.2M in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2022.

Based on TimesSquare Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.